- Capital Cube•19 days ago
Categories: Yahoo Finance Get free summary analysis Cleveland BioLabs, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Cleveland BioLabs, Inc. – OPKO Health, Inc., Novartis AG Sponsored ADR, Bristol-Myers Squibb Company, Cascadian Therapeutics Inc., Amgen Inc., Eli Lilly and Company and GlaxoSmithKline plc Sponsored ADR ... Read more (Read more...)
- Marketwired•20 days ago
Cleveland BioLabs, Inc. today reported financial results and development progress for the third quarter ended September 30, 2016.
- Marketwired•2 months ago
Cleveland BioLabs, Inc. today announced that the Department of Defense has modified its Joint Warfighter Medical Research Program contract award number W81XWH-15-C-0101 with CBLI valued at up to $9.2 million ...
CBLI : Summary for Cleveland BioLabs, Inc. - Yahoo Finance
Cleveland BioLabs, Inc. (CBLI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||1.57 - 1.63|
|52 Week Range||1.45 - 4.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.15|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|